Embryonic wound healing is both a mechanical process, driven by intra-and intercellular forces, and a genetic process, regulated by an array of signalling molecules.
ulated by an array of signalling molecules.
Our goal is to understand the fundamental biology and dynamics of embryonic wound healing -to connect the phenomenology of wound-margin shortening to the underlying cytoskeletal mechanics and genetic regulatory networks.
As a model system, we are using the epidermal tissue of fruit fly embryos (Drosophila melanogaster) at stage 15, just after formation of the epidermis. This system is well-suited to integrated genetic and mechanical studies because we can generate precise wounds with laser-microsurgery, and follow the cellular details of wound closure in living, GFP-labeled embryos, both in wild type and in mutants, via confocal microscopy. We are collaborating with a group of computational biologists to generate a mathematical model of wound healing that will help us to understand this process. Previously, we reported that EPB41L5 (erythrocyte protein band4.1-like5) plays essential roles in the loss of E-cadherin and expression of integrin on cell surfaces during EMT of NMuMG cells. The Arf6 protein has been implicated in the endocytosis of E-cadherin and the activation of Arf6 by GEP100 has been shown to disrupt E-cadherin-based cell-cell adhesion. Here we report that an active Arf6 mutant, Arf6Q67L, which cannot be hydrolyzed, recruits EPB41L5 to the plasma membrane and EPB41L5 binds to AMAP1, a effector for GTP-Arf6. Immunoprecipitation analysis showed that Arf6Q67L coprecipitates with EPB41L5. GEP100 is known to bind to a-catenin and, together with Arf6 and AMAP1 is also thought to function in integrin recycling.
The details of the interaction among EPB41L5, Arf6, AMAP1 and GEP100 will be discussed. 
